EANM procedure guideline for brain perfusion SPECT using 99mTc-labelled radiopharmaceuticals, version 2

  • Özlem L. Kapucu
  • Flavio Nobili
  • Andrea Varrone
  • Jan Booij
  • Thierry Vander Borght
  • Kjell Någren
  • Jacques Darcourt
  • Klaus Tatsch
  • Koen J. Van Laere
Guidelines

Abstract

These guidelines summarize the current views of the European Association of Nuclear Medicine Neuroimaging Committee (ENC). The purpose of the guidelines is to assist nuclear medicine practitioners when making recommendations, performing, interpreting, and reporting the results of brain perfusion single photon emission computed tomography (SPECT) studies using 99mTc-labelled radiopharmaceuticals. The aim is to achieve a high quality standard for brain perfusion SPECT imaging, which will increase the diagnostic impact of this technique in clinical practice. The present document replaces a former version of the guideline published in 2001 which was inspired by the Society of Nuclear Medicine Procedure Guideline for Brain Perfusion SPECT [1], the views of the Society of Nuclear Medicine Brain Imaging Council [2], and the individual experience of experts in European countries. The guidelines are intended to present information specifically adapted to European practice. The information provided should be taken in the context of local conditions and regulations.

Keywords

Brain Perfusion SPECT HMPAO ECD Epilepsy Dementia 

References

  1. 1.
    Juni JE, Waxman AD, Devous MD Sr, Tikofsky RS, Ichise M, Van Heertum RL, et al. Society of Nuclear Medicine procedure guideline for brain perfusion single photon computed tomography (SPECT) using Tc-99 m radiopharmaceuticals. Procedure Guidelines Manual June 2002. Reston, VA: Society of Nuclear Medicine; 2002. p. 113–118.Google Scholar
  2. 2.
    Society of Nuclear Medicine Brain Imaging Council. Ethical clinical practice of functional brain imaging. J Nucl Med 1996;37:1256–59.Google Scholar
  3. 3.
    Reba RC, Holman BL. Brain perfusion radiotracers. In: Diksic M, Reba RC, editors. Radiopharmaceuticals and brain pathology studied with PET and SPECT. Boca Raton: CRC Press; 1990.Google Scholar
  4. 4.
    Inoue K, Nakagawa M, Goto R, Kinomura S, Sato T, Sato K, et al. Regional differences between 99mTc-ECD and 99mTc-HMPAO SPECT in perfusion changes with age and gender in healthy adults. Eur J Nucl Med Mol Imaging 2003;30:1489–97.CrossRefPubMedGoogle Scholar
  5. 5.
    Friedman NC, Burt RW. Cerebral perfusion imaging. In: Henkin RE, Bova D, Dillehay L, Karesh SM, Halama JR, Wagner RH, editors. Nuclear medicine. 2nd ed. Philadelphia: Mosby-Elsevier; 2006. p. 1255–81.Google Scholar
  6. 6.
    Latchaw RE, Yonas H, Hunter GJ, Yuh WT, Ueda T, Sorensen AG, et al. Guidelines and recommendations for perfusion imaging in cerebral ischemia: a scientific statement for healthcare professionals by the writing group on perfusion imaging, from the Council on Cardiovascular Radiology of the American Heart Association. Stroke 2003;34:1084–104.CrossRefPubMedGoogle Scholar
  7. 7.
    Masdeu JC, Irimia P, Asenbaum S, Bogousslavsky J, Brainin M, Chabriat H, et al. EFNS guideline on neuroimaging in acute stroke. Report of an EFNS task force. Eur J Neurol 2006;13:1271–83.CrossRefPubMedGoogle Scholar
  8. 8.
    Mountz JM, Liu HG, Deutsch G. Neuroimaging in cerebrovascular disorders: measurement of cerebral physiology after stroke and assessment of stroke recovery. Semin Nucl Med 2003;33:56–76.CrossRefPubMedGoogle Scholar
  9. 9.
    Aso K, Ogasawara K, Sasaki M, Kobayashi M, Suga Y, Chida K, et al. Preoperative cerebrovascular reactivity to acetazolamide measured by brain perfusion SPECT predicts development of cerebral ischemic lesions caused by microemboli during carotid endarterectomy. Eur J Nucl Med Mol Imaging 2009;26:294–301.CrossRefGoogle Scholar
  10. 10.
    Lee TH, Kim SJ, Kim IJ, Kim YK, Kim DS, Park KP. Statistical parametric mapping and statistical probabilistic anatomical mapping analyses of basal/acetazolamide Tc-99m ECD brain SPECT for efficacy assessment of endovascular stent placement for middle cerebral artery stenosis. Neuroradiology 2007;49:289–98.CrossRefPubMedGoogle Scholar
  11. 11.
    Lee HY, Paeng JC, Lee DS, Lee JS, Oh CW, Cho MJ, et al. Efficacy assessment of cerebral arterial bypass surgery using statistical parametric mapping and probabilistic brain atlas on basal/acetazolamide brain perfusion SPECT. J Nucl Med 2004;45:202–6.PubMedGoogle Scholar
  12. 12.
    Sugawara Y, Kikuchi T, Ueda T, Sugawara Y, Kikuchi T, Ueda T, et al. Usefulness of brain SPECT to evaluate brain tolerance and hemodynamic changes during temporary balloon occlusion test and after permanent carotid occlusion. J Nucl Med 2002;43(12):1616–23.PubMedGoogle Scholar
  13. 13.
    Goffin K, Dedeurwaerdere S, Van Laere K, Van Paesschen W. Neuronuclear assessment of patients with epilepsy. Semin Nucl Med 2008;38:227–39.CrossRefPubMedGoogle Scholar
  14. 14.
    Van Paesschen W, Dupont P, Sunaert S, Goffin K, Van Laere K. The use of SPECT and PET in routine clinical practice in epilepsy. Curr Opin Neurol 2007;20:194–202.CrossRefPubMedGoogle Scholar
  15. 15.
    Van Paesschen W. Ictal SPECT. Epilepsia 2004;45(Suppl 4):35–40.CrossRefPubMedGoogle Scholar
  16. 16.
    Zaknun JJ, Bal C, Maes A, Tepmongkol S, Vazquez S, Dupont P, et al. Comparative analysis of MR imaging, Ictal SPECT and EEG in temporal lobe epilepsy: a prospective IAEA multi-center study. Eur J Nucl Med Mol Imaging 2008;35:107–15.CrossRefPubMedGoogle Scholar
  17. 17.
    Patil S, Biassoni L, Borgwardt L. Nuclear medicine in pediatric neurology and neurosurgery: epilepsy and brain tumors. Semin Nucl Med 2007;37:357–81.CrossRefPubMedGoogle Scholar
  18. 18.
    Devous MD Sr. Functional brain imaging in the dementias: role in early detection, differential diagnosis, and longitudinal studies. Eur J Nucl Med Mol Imaging 2002;29:1685–96.CrossRefPubMedGoogle Scholar
  19. 19.
    Matsuda H. Role of neuroimaging in Alzheimer's disease, with emphasis on brain perfusion SPECT. J Nucl Med 2007;48:1289–300.CrossRefPubMedGoogle Scholar
  20. 20.
    Kemp PM, Holmes C. Imaging in dementia with Lewy bodies: a review. Nucl Med Commun 2007;28:511–9.CrossRefPubMedGoogle Scholar
  21. 21.
    Chang CC, Liu JS, Chang YY, Chang WN, Chen SS, Lee CH. (99 m)Tc-ethyl cysteinate dimer brain SPECT findings in early stage of dementia with Lewy bodies and Parkinson's disease patients: a correlation with neuropsychological tests. Eur J Neurol 2008;15:61–5.CrossRefPubMedGoogle Scholar
  22. 22.
    Kato H, Yoshikawa T, Oku N, Imaizumi M, Takasawa M, Kimura Y, et al. Statistical parametric analysis of cerebral blood flow in vascular dementia with small-vessel disease using Tc-HMPAO SPECT. Cerebrovasc Dis 2008;26:556–62.CrossRefPubMedGoogle Scholar
  23. 23.
    Le Ber I, Guedj E, Gabelle A, Verpillat P, Volteau M, Thomas-Anterion C, et al. Demographic, neurological and behavioural characteristics and brain perfusion SPECT in frontal variant of frontotemporal dementia. Brain 2006;129:3051–65.CrossRefPubMedGoogle Scholar
  24. 24.
    Johnson KA, Moran EK, Becker JA, Blacker D, Fischman AJ, Albert MS. Single photon emission computed tomography perfusion differences in mild cognitive impairment. J Neurol Neurosurg Psychiatry 2007;78:240–7.CrossRefPubMedGoogle Scholar
  25. 25.
    Newberg AB, Alavi A. Neuroimaging in patients with head injury. Semin Nucl Med 2003;33:136–47.CrossRefPubMedGoogle Scholar
  26. 26.
    Yacubian EM, Marie SK, Valério RM, Jorge CL, Yamaga L, Buchpiguel CA. Neuroimaging findings in Rasmussen's syndrome. J Neuroimaging 1997;7:16–22.PubMedGoogle Scholar
  27. 27.
    Launes J, Sirén J, Valanne L, Salonen O, Nikkinen P, Seppäläinen AM, et al. Unilateral hyperperfusion in brain-perfusion SPECT predicts poor prognosis in acute encephalitis. Neurology 1997;48:1347–51.PubMedGoogle Scholar
  28. 28.
    Kao CH, Chan JL, ChangLai SP, Liao KK, Chieng PU. The role of FDG-PET, HMPAO SPECT and MRI in the detection of brain involvement in patients with systemic lupus erythematosus. Eur J Nucl Med 1999;26:129–34.CrossRefPubMedGoogle Scholar
  29. 29.
    Vignola S, Nobili F, Picco P, Gattorno M, Buoncompagni A, Vitali P, et al. Brain perfusion SPECT in juvenile neuro-Behçet's disease. J Nucl Med 2001;42:1151–7.PubMedGoogle Scholar
  30. 30.
    Tucker KA, Robertson KR, Lin W, Smith JK, An H, Chen Y, et al. Neuroimaging in human immunodeficiency virus infection. J Neuroimmunol 2004;157:153–62.CrossRefPubMedGoogle Scholar
  31. 31.
    Donohoe KJ, Frey KA, Gerbaudo VH, Mariani G, Nagel JS, Shulkin B. Procedure guideline for brain death scintigraphy. J Nucl Med 2003;44:846–51.PubMedGoogle Scholar
  32. 32.
    Smith DJ, Cavanagh JT. The use of single photon emission computed tomography in depressive disorders. Nucl Med Commun 2005;26:197–203.CrossRefPubMedGoogle Scholar
  33. 33.
    Thomsen G, de Nijs R, Hogh-Rasmussen E, Frokjaer V, Svarer C, Knudsen GM. Required time delay from Tc-99 m HMPAO injection to SPECT data acquisition: healthy subjects and patients with rCBF pattern. Eur J Nucl Med Mol Imaging 2009;35:2212–9.CrossRefGoogle Scholar
  34. 34.
    Bartenstein P, Minoshima S, Hirsch C, Buch K, Willoch F, Mösch D, et al. Quantitative assessment of cerebral blood flow in patients with Alzheimer's disease by SPECT. J Nucl Med 1997;38:1095–101.PubMedGoogle Scholar
  35. 35.
    Friston KJ. Introduction: experimental design and statistical parametric mapping. In: Frackowiak RSJ, Friston KJ, Frith C, editors. Human brain function. 2nd ed. New York: Academic Press; 2003.Google Scholar
  36. 36.
    McNally KA, Paige AL, Varghese G, Zhang H, Novotny EJ Jr, Spencer SS, et al. Localizing value of ictal-interictal SPECT analyzed by SPM (ISAS). Epilepsia 2005;46:1450–64.CrossRefPubMedGoogle Scholar
  37. 37.
    Kaiboriboon K, Lowe VJ, Chantarujikapong SI, Hogan RE. The usefulness of subtraction ictal SPECT coregistered to MRI in single- and dual-headed SPECT cameras in partial epilepsy. Epilepsia 2002;43:408–14.CrossRefPubMedGoogle Scholar
  38. 38.
    Dupont P, Van Paesschen W, Palmini A, Ambayi R, Van Loon J, Goffin J, et al. Ictal perfusion patterns associated with single MRI-visible focal dysplastic lesions: implications for the noninvasive delineation of the epileptogenic zone. Epilepsia 2006;47:1550–7.CrossRefPubMedGoogle Scholar
  39. 39.
    Seo Y, Mari C, Hasegawa BH. Technological development and advances in single-photon emission computed tomography/computed tomography. Semin Nucl Med 2008;38:177–98.CrossRefPubMedGoogle Scholar
  40. 40.
    Grova C, Jannin P, Biraben A, Buvat I, Benali H, Bernard AM, et al. A methodology for generating normal and pathological brain perfusion SPECT images for evaluation of MRI/SPECT fusion methods: application in epilepsy. Phys Med Biol 2003;48:4023–43.CrossRefPubMedGoogle Scholar

Copyright information

© EANM 2009

Authors and Affiliations

  • Özlem L. Kapucu
    • 1
  • Flavio Nobili
    • 2
  • Andrea Varrone
    • 3
  • Jan Booij
    • 4
  • Thierry Vander Borght
    • 5
  • Kjell Någren
    • 6
  • Jacques Darcourt
    • 7
  • Klaus Tatsch
    • 8
  • Koen J. Van Laere
    • 9
  1. 1.Department of Nuclear Medicine, Faculty of MedicineGazi UniversityAnkaraTurkey
  2. 2.Clinical Neurophysiology Unit, San Martino HospitalUniversity of GenoaGenoaItaly
  3. 3.Department of Clinical Neuroscience, Psychiatry SectionKarolinska InstitutetStockholmSweden
  4. 4.Department of Nuclear Medicine, Academic Medical CenterUniversity of AmsterdamAmsterdamThe Netherlands
  5. 5.Nuclear Medicine DivisionUniversité Catholique de Louvain, Mont-Godinne Medical CenterLouvain-la-NeuveBelgium
  6. 6.Department of Clinical Physiology and Nuclear Medicine, RigshospitaletUniversity of CopenhagenCopenhagenDenmark
  7. 7.Nuclear Medicine, Centre Antoine Lacassagne and University HospitalUniversité de Nice Sophia AntipolisNiceFrance
  8. 8.Department of Nuclear Medicine, Municipal Hospital of Karlsruhe Inc.KarlsruheGermany
  9. 9.Division of Nuclear MedicineUniversity Hospital LeuvenLeuvenBelgium

Personalised recommendations